Skip to content

Neuroplasticity: all studies

Page 110 of 178: studies 1,091 to 1,100 of 1,772, newest first. Back to the neuroplasticity overview

Research

BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW

Health Problems of Civilization February 20, 2025 Julia Wójcik, Kacper Wojciech Pamuła, Marcin Cholewa et al.

Psylocybina to psychoaktywny związek chemiczny występujący w grzybach z rodzaju Psilocybe, które zyskały znaczną popularność w ostatniej dekadzie ze względu na ich wpływ na neuroplastyczność, działanie serotoninergiczne oraz zdolność do tworzenia nowych połączeń między obszarami, które komunikowały się wcześniej ze sobą. Celem niniejszego badania jest ocena potencjalnych zastosowań psylocybiny...

Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome

Journal of Clinical Gastroenterology February 17, 2025 Erin Mauney, Franklin King, Helen Burton-Murray et al. 3 citations

Irritable bowel syndrome (IBS) is prevalent and can be disabling. Many patients remain symptomatic despite behavioral and medical therapies. Psychedelic-assisted therapy (PAT), in which serotonergic agents like psilocybin are administered in a psychotherapeutic context, has shown promise for refractory psychiatric disorders, including major depressive disorder and post-traumatic stress...

Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression

Nature Communications February 12, 2025 Farid Aboharb, Pasha A. Davoudian, Ling-Xiao Shao et al. 19 citations

Psilocybin, ketamine, and MDMA are psychoactive compounds that exert behavioral effects with distinguishable but also overlapping features. The growing interest in using these compounds as therapeutics necessitates preclinical assays that can accurately screen psychedelics and related analogs. We posit that a promising approach may be to measure drug action on markers of neural plasticity in...

Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial).

BMJ Open February 10, 2025 Kathryn Fletcher, Nadine Ezard, Krista J. Siefried et al. 1 citation

Methamphetamine use disorder is a significant public health concern. No pharmacological treatment options currently exist for methamphetamine use disorder, and psychotherapy is only moderately effective. Preliminary evidence suggests that ketamine-assisted psychotherapy produces sustained improvements in substance use and mental health symptomatology. In addition to direct antidepressant...

DOI: 10.1136/bmjopen-2024-092504 (opens in new tab) Full text (opens in new tab) Drug therapy Feasibility studies Psychosocial intervention Safety +6

Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders

ACS Pharmacology & Translational Science February 10, 2025 Xue Wang, Cong Lin, Xiaohui Wang 5 citations

Autism Spectrum Disorders (ASD) are complex neurodevelopmental conditions characterized by deficits in social interaction, communication, and repetitive behaviors. This viewpoint explores the potential mechanisms through which psychedelics such as lysergic acid diethylamide (LSD), psilocybin, and 3,4-methylenedioxymethamphetamine (MDMA) may positively influence pro-social behaviors, focusing on...

DOI: 10.1021/acsptsci.5c00034 (opens in new tab) Mental health treatment Psychedelics Autism spectrum disorders Social cognition

AI-Enhanced Neuroengineering: Brain Uploading, Memory Transfer, and the Future of Consciousness

February 9, 2025 Murali Krishna Pasupuleti 1 citation

Abstract: The convergence of artificial intelligence (AI) and neuroengineering is redefining the future of human cognition, paving the way for brain uploading, memory transfer, and digital consciousness. This chapter explores the scientific and philosophical dimensions of AI-driven neural interfaces, high-resolution brain mapping, and whole-brain emulation (WBE), examining how AI enhances our...

Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential.

Neuroscience February 6, 2025 Carolina Echeverry, Mariana Pazos, Maximiliano Torres-Pérez et al. 9 citations

Neurodegenerative diseases are a group of disorders characterized by progressive degeneration of discrete groups of neurons causing severe disability. The main risk factor is age, hence their incidence is rapidly increasing worldwide due to the rise in life expectancy. Although the causes of the disease are not identified in about 90% of the cases, in the last decades there has been great...

Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology

bioRxiv (Cold Spring Harbor Laboratory) February 6, 2025 Bryce Axe, Ashwath Maheswari, Reagan Walhof et al. 3 citations preprint

Abstract Repetitive mild head injuries incurred while playing organized sports, during car accidents and falls, or in active military service are a major health problem. These head injuries induce cognitive, motor, and behavioral deficits that can last for months and even years with an increased risk of dementia, Parkinson’s disease, and chronic traumatic encephalopathy. There is no approved...

Ketamine induces plasticity in a norepinephrine-astroglial circuit to promote behavioral perseverance.

Neuron February 5, 2025 Marc Duque, Alex B. Chen, Eric Hsu et al. 27 citations

Transient exposure to ketamine can trigger lasting changes in behavior and mood. We found that brief ketamine exposure causes long-term suppression of futility-induced passivity in larval zebrafish, reversing the "giving-up" response that normally occurs when swimming fails to cause forward movement. Whole-brain imaging revealed that ketamine hyperactivates the norepinephrine-astroglia circuit...

MULTIOMIC PROFILING OF RAPID ANTIDEPRESSANT MECHANISMS IN A RAT MODEL OF DEPRESSION

The International Journal of Neuropsychopharmacology February 1, 2025 *Laura Musazzi, J. Mingardi, P. Misztak et al.

Abstract Background The stress response is a physiological event finely orchestrated by the brain and aimed at restoring the homeostasis lost in case of environmental changes perceived as dangerous for survival. Most subjects successfully activate an adaptive stress response however, when the exposure to stressful stimuli is prolonged over time or overwhelming, some individuals may fail in...